Development of a rapid quantitative method to differentiate MS1 vaccine strain from wild-type Mycoplasma synoviae

Area of Science:

• Veterinary Microbiology
• Molecular Diagnostics
• Poultry Pathology

Background:

• Mycoplasma synoviae (MS) poses significant economic challenges to the poultry industry.
• Effective vaccination strategies are essential for controlling MS infections in poultry.
• Distinguishing between vaccine and wild-type (WT) MS strains is critical for disease surveillance post-vaccination.

Purpose of the Study:

• To develop a novel Taqman duplex real-time polymerase chain reaction (PCR) assay.
• To enable specific identification and differentiation of the MS1 vaccine strain from WT MS strains in a single reaction.

Main Methods:

• Development of a Taqman duplex real-time PCR assay.
• Specificity testing against other avian pathogens.
• Sensitivity assessment, including evaluation of probe and template interactions in duplex reactions.
• Comparison with the melt-based mismatch amplification mutation assay (MAMA).

Main Results:

• The developed Taqman duplex real-time PCR method demonstrated high specificity, with no cross-reactivity observed against other avian pathogens.
• Sensitivity assays confirmed no inhibition between probes or between mixed and pure templates during duplex real-time PCR.
• The new method proved to be more sensitive and faster than the melt-based mismatch amplification mutation assay (MAMA).

Conclusions:

• The Taqman duplex real-time PCR assay is a valuable tool for the simultaneous diagnosis and differentiation of WT-MS and MS1 vaccine strains.
• This method offers a reliable and efficient approach for monitoring MS infection dynamics in vaccinated poultry populations.